PARATHYROID HORMONE-INDUCED DOPAMINE TURNOVER IN THE RAT MEDIAL BASAL HYPOTHALAMUS

被引:20
作者
HARVEY, S [1 ]
HAYER, S [1 ]
SLOLEY, BD [1 ]
机构
[1] UNIV ALBERTA, DEPT ZOOL, EDMONTON T69 2H7, AB, CANADA
基金
英国医学研究理事会;
关键词
PARATHYROID HORMONE (PTH); DOPAMINE; DOPAC; HYPOTHALAMUS;
D O I
10.1016/0196-9781(93)90041-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The parathyroid hormone (PTH) gene is expressed and translated in the rat hypothalamus, and the possibility that PTH may modulate neural activity was therefore examined in anesthetized rats. Intracerebroventricular (ICV) injections of 1.0 or 10.0 mug rat, human, or bovine PTH(1-34) was followed 60 min later by increased concentrations of DOPAC (dihydroxyacetic acid) and the DOPAC:dopamine (DA) ratio in the medial basal hypothalamus (MBH), but not in other (brainstem, cerebral cortex, cerebellum) regions of the brain. Tissue concentrations of norepinephrine and serotonin were unchanged by ICV PTH administration, although MBH concentrations of 5-hydroxyindolacetic acid (5-HIAA) were increased following PTH administration. An increase in MBH DA turnover (as indicated by an increased DOPAC: DA ratio) was also induced by the ICV injection of 10 mug PTH-related protein [PTHrP(1-34)]. Pretreatment with the receptor antagonists PTH(7-34) or PTHrP(7-34) completely blocked the subsequent DOPAC response to ICV PTH or PTHrP, respectively. The DOPAC concentrations in hypothalamic extracellular fluid (ECF), sampled by microdialysis, were also increased within 20 min of PTH(1-34) perfusion, in the absence of changes in the ECF concentrations of 5-HIAA, These results demonstrate that PTH and PTH-like peptides specifically increase DA turnover in the rat MBH and suggest novel roles for these hormones in neural regulation.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 40 条
[1]   ROLE OF UREMIA, BRAIN CALCIUM, AND PARATHYROID-HORMONE ON CHANGES IN ELECTROENCEPHALOGRAM IN CHRONIC-RENAL-FAILURE [J].
AKMAL, M ;
GOLDSTEIN, DA ;
MULTANI, S ;
MASSRY, SG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (05) :F575-F579
[2]  
ALLEN EM, 1970, NEUROLOGY, V20, P125
[3]  
BENJONATHAN N, 1991, FRONT NEUROENDOCRIN, V12, P231
[4]  
CARE AD, 1986, 9TH P INT C CALC REG, P181
[5]   EFFECTS OF PARATHYROID-HORMONE INFUSION AND PRIMARY HYPERPARATHYROIDISM ON SERUM PROLACTIN IN MAN [J].
CASTRO, JH ;
CARO, JF ;
KIM, HJ ;
GLENNON, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (02) :397-398
[6]   EFFECT OF PARATHYROID-HORMONE, CENTRALLY OR PERIPHERALLY INJECTED, ON GASTRIC ACTIVITY IN MALE-RATS [J].
CLEMENTI, G ;
CARUSO, A ;
FIORE, CE ;
LEONE, MG ;
PRATO, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :549-552
[7]   EFFECTS OF CALCITONIN, PARATHYROID-HORMONE AND ITS RELATED FRAGMENTS ON ACQUISITION OF ACTIVE-AVOIDANCE BEHAVIOR [J].
CLEMENTI, G ;
DRAGO, F ;
PRATO, A ;
CAVALIERE, S ;
DIBENEDETTO, A ;
LEONE, F ;
SCAPAGNINI, U ;
RODOLICO, G .
PHYSIOLOGY & BEHAVIOR, 1984, 33 (06) :913-916
[8]   CENTRAL NERVOUS-SYSTEM MANIFESTATIONS OF HYPER-PARATHYROIDISM [J].
COGAN, MG ;
COVEY, CM ;
ARIEFF, AI ;
WISNIEWSKI, A ;
CLARK, OH ;
LAZAROWITZ, V ;
LEACH, W .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (06) :963-970
[9]   NEURODIAGNOSTIC ABNORMALITIES IN PATIENTS WITH ACUTE RENAL-FAILURE - EVIDENCE FOR NEUROTOXICITY OF PARATHYROID-HORMONE [J].
COOPER, JD ;
LAZAROWITZ, VC ;
ARIEFF, AI .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (06) :1448-1455
[10]  
DUBOVSKY SL, 1983, BIOL PSYCHIAT, V18, P781